GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Retained Earnings

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Retained Earnings : $-23.43 Mil (As of Sep. 2019)


View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. OWC Pharmaceutical Research's retained earnings for the quarter that ended in Sep. 2019 was $-23.43 Mil.

OWC Pharmaceutical Research's quarterly retained earnings increased from Mar. 2019 ($-29.28 Mil) to Jun. 2019 ($-22.38 Mil) but then declined from Jun. 2019 ($-22.38 Mil) to Sep. 2019 ($-23.43 Mil).

OWC Pharmaceutical Research's annual retained earnings declined from Dec. 2016 ($-9.96 Mil) to Dec. 2017 ($-14.52 Mil) and declined from Dec. 2017 ($-14.52 Mil) to Dec. 2018 ($-27.22 Mil).


OWC Pharmaceutical Research Retained Earnings Historical Data

The historical data trend for OWC Pharmaceutical Research's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Retained Earnings Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Retained Earnings
Get a 7-Day Free Trial Premium Member Only -5.89 -7.55 -9.96 -14.52 -27.22

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.14 -27.22 -29.28 -22.38 -23.43

OWC Pharmaceutical Research Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


OWC Pharmaceutical Research  (OTCPK:OWCP) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Traded in Other Exchanges
N/A
Address
2 Ben Gurion Street, Ramat Gan, ISR, 5257334
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Executives
Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Headlines

From GuruFocus

OWC Pharmaceutical Research Corp Letter to Shareholders

By PRNewswire PRNewswire 07-24-2018

OWC Pharmaceutical Research Corp Announced Personnel Changes

By PRNewswire PRNewswire 08-21-2018